CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net income	$ 31,813	$ 4,693	$ 344,094
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	14,009	13,794	13,338
Stock-based compensation expense	8,159	7,959	6,135
Inventory impairments and abandonments	2,445	15,282	3,109
Deferred and other income tax expense (benefit)	678	15,903	(326,360)
Write-off of deposit on legacy land investment	2,700	0	0
Gain on sale of fixed assets	(294)	(957)	0
Change in allowance for doubtful accounts	(24)	(698)	(193)
Equity in (income) loss of unconsolidated entities and marketable securities	(401)	(143)	1,294
Cash distributions of income from unconsolidated entities	171	165	224
Non-cash loss on extinguishment of debt	3,677	4,978	0
Changes in operating assets and liabilities:
Decrease (increase) in accounts receivable	16,927	(149)	(17,757)
Decrease (increase) in income tax receivable	204	127	(373)
Decrease (increase) in inventory	41,911	129,028	(121,700)
Increase in other assets	(168)	(471)	(165)
(Decrease) increase in trade accounts payable	(690)	(9,365)	7,302
(Decrease) increase in other liabilities	(25,208)	(17,121)	10,260
Other changes	0	0	(257)
Net cash provided by (used in) operating activities	95,909	163,025	(81,049)
Cash flows from investing activities:
Capital expenditures	(12,440)	(12,219)	(15,964)
Proceeds from sale of fixed assets	297	2,624	0
Investments in unconsolidated entities	(3,261)	(4,241)	(4,944)
Return of capital from unconsolidated entities and marketable securities	1,621	1,142	24,245
Net cash (used in) provided by investing activities	(13,783)	(12,694)	3,337
Cash flows from financing activities:
Repayment of debt	(265,483)	(828,221)	(18,573)
Proceeds from issuance of new debt	250,000	642,150	0
Repayment of borrowings from credit facility	(25,000)	(90,000)	(75,000)
Borrowings from credit facility	25,000	90,000	75,000
Debt issuance costs	(4,919)	(11,246)	(126)
Other changes	(391)	(222)	(200)
Net cash used in financing activities	(20,793)	(197,539)	(18,899)
Increase (decrease) in cash, cash equivalents and restricted cash	61,333	(47,208)	(96,611)
Cash, cash equivalents and restricted cash at beginning of period	243,276	290,484	387,095
Cash, cash equivalents and restricted cash at end of period	$ 304,609	$ 243,276	$ 290,484